The analysis of clinical SCLC tissues revealed that Kir2.1 overexpression was negatively associated with the chemotherapeutic response of SCLC patients, suggesting a potential predictive role of these channels in SCLC treatment. The gene discussed is KCNJ2; the disease is small cell lung carcinoma.